Can axillary lymph node dissection be avoided in patients with locally advanced breast cancer following neoadjuvant chemotherapy?

dc.contributor.author	Tukenmez, Mustafa
dc.contributor.author	Trabulus, D.
dc.contributor.author	Dinccag, A.
dc.contributor.author	Muslumanoglu, M.
dc.contributor.author	Cabioglu, Neslihan
dc.contributor.author	Dogan, S.
dc.contributor.author	Igci, A.
dc.contributor.author	Ozmen, V.
dc.contributor.author	Ozkurt, E.
dc.contributor.author	Emirikci, S.
dc.date.accessioned	2021-03-05T20:14:38Z
dc.date.available	2021-03-05T20:14:38Z
dc.identifier.citation	Emirikci S., Cabioglu N., Trabulus D., Ozkurt E., Tukenmez M., Dogan S., Igci A., Ozmen V., Dinccag A., Muslumanoglu M., "Can axillary lymph node dissection be avoided in patients with locally advanced breast cancer following neoadjuvant chemotherapy?", 11th European Breast Cancer Conference (EBCC), Barcelona, İspanya, 21 - 23 Mart 2018, cilt.92
dc.identifier.other	vv_1032021
dc.identifier.other	av_d32a21e9-f7dd-4641-a365-ad6d6c988294
dc.identifier.uri	http://hdl.handle.net/20.500.12627/139439
dc.language.iso	eng
dc.subject	Health Sciences
dc.subject	Sağlık Bilimleri
dc.subject	Dahili Tıp Bilimleri
dc.subject	İç Hastalıkları
dc.subject	Onkoloji
dc.subject	Oncology
dc.subject	ONKOLOJİ
dc.subject	Klinik Tıp
dc.subject	Klinik Tıp (MED)
dc.subject	Tıp
dc.title	Can axillary lymph node dissection be avoided in patients with locally advanced breast cancer following neoadjuvant chemotherapy?
dc.type	Bildiri
dc.contributor.department	İstanbul Üniversitesi , ,
dc.identifier.volume	92
dc.contributor.firstauthorID	153077

Files in this item

Files	Size	Format	View
There are no files associated with this item.